Back to Search Start Over

Australian fertility preservation guidelines for people with cancer 2022: review and recommendations.

Authors :
Kieu, Violet
Stern, Catharyn
Harris, Jessica
Jayasinghe, Yasmin
Bradford, Natalie
Cui, Wanyuan
Deans, Rebecca
Hunter, Tamara
Allingham, Catherine
Kane, Stefan C
Lau, Lei Shong
Logan, Shanna
McLachlan, Robert
Neville, Kristen
Peate, Michelle
Phillips, Marianne
Saunders, Carla
Tome, Marianne
Upreti, Rita
White, Kate
Source :
Medical Journal of Australia; Dec2022, Vol. 217 Issue 11, p564-569, 6p
Publication Year :
2022

Abstract

Mature oocyte cryopreservation provides a realistic opportunity for future pregnancy for female patients with cancer.[18] The age of the patient and the number of oocytes retrieved will influence the number of opportunities for pregnancy. Fertility preservation treatment is often urgent to prevent a delay in commencing cancer treatments. It is advisable that patients with cancer be offered pre-pregnancy counselling</td><td>III-2</td><td>C</td></tr></tbody></table> ht Effective contraception is required during chemotherapy for women undergoing cancer treatment and immediately after treatment. Women who receive cancer treatment may be more likely to have reduced ovarian reserve than those who have not undergone cancer treatment.[8] Furthermore, sperm quality is reduced in men previously treated for cancer compared with the general population.[9] Azoospermia may occur after cancer treatment including chemotherapy and radiation. [Extracted from the article]

Details

Language :
English
ISSN :
0025729X
Volume :
217
Issue :
11
Database :
Complementary Index
Journal :
Medical Journal of Australia
Publication Type :
Academic Journal
Accession number :
160650125
Full Text :
https://doi.org/10.5694/mja2.51751